These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 22210482)

  • 1. Willingness of clinicians to integrate microbicides into HIV prevention practices in southern Africa.
    Harper CC; Holt K; Nhemachena T; Chipato T; Ramjee G; Stratton L; Blum M; McCulloch CE; Mgweba S; Blanchard K
    AIDS Behav; 2012 Oct; 16(7):1821-9. PubMed ID: 22210482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Provision of long-acting reversible contraception in HIV-prevalent countries: results from nationally representative surveys in southern Africa.
    Morse J; Chipato T; Blanchard K; Nhemachena T; Ramjee G; McCulloch C; Blum M; Saleeby E; Harper CC
    BJOG; 2013 Oct; 120(11):1386-94. PubMed ID: 23721413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engaging male partners in women's microbicide use: evidence from clinical trials and implications for future research and microbicide introduction.
    Lanham M; Wilcher R; Montgomery ET; Pool R; Schuler S; Lenzi R; Friedland B
    J Int AIDS Soc; 2014; 17(3 Suppl 2):19159. PubMed ID: 25224618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Male circumcision for HIV prevention: clinical practices and attitudes among healthcare providers in South Africa and Zimbabwe.
    Sheldon WR; Nhemachena T; Blanchard K; Chipato T; Ramjee G; Trussell J; McCulloch CE; Blum M; Harper CC
    Sex Transm Dis; 2012 Jul; 39(7):567-75. PubMed ID: 22706221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health practices and vaginal microbicide acceptability among urban black women.
    Reiff M; Wade C; Chao MT; Kronenberg F; Cushman LF
    J Womens Health (Larchmt); 2008 Oct; 17(8):1345-51. PubMed ID: 18788991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical microbicides for prevention of sexually transmitted infections.
    Obiero J; Mwethera PG; Wiysonge CS
    Cochrane Database Syst Rev; 2012 Jun; (6):CD007961. PubMed ID: 22696373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knowledge of HIV prevention and willingness to collaborate in vaginal microbicides trials-survey of Nigerian gynecologists.
    Musa J; Adamu IS; Muhammad Z; Egbodo C; Mohammed C
    Niger J Med; 2012; 21(2):185-9. PubMed ID: 23311188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Condoms, Lubricants and Rectal Cleansing: Practices Associated with Heterosexual Penile-Anal Intercourse Amongst Participants in an HIV Prevention Trial in South Africa, Uganda and Zimbabwe.
    Duby Z; Hartmann M; Montgomery ET; Colvin CJ; Mensch B; van der Straten A
    AIDS Behav; 2016 Apr; 20(4):754-62. PubMed ID: 26126586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Women's interest in vaginal microbicides.
    Darroch JE; Frost JJ
    Fam Plann Perspect; 1999; 31(1):16-23. PubMed ID: 10029928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Communicating about microbicides with women in mind: tailoring messages for specific audiences.
    Sidibe S; Pack AP; Tolley EE; Ryan E; Mackenzie C; Bockh E; Githuka G
    J Int AIDS Soc; 2014; 17(3 Suppl 2):19151. PubMed ID: 25224612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How effective is effective enough? Opinions of potential end-users of microbicides from a rural South African community.
    Gafos M; Mzimela MA; Ndlovu HB; McCormack S; McGrath N
    AIDS Care; 2013; 25(5):573-8. PubMed ID: 22971053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges to microbicide introduction in South Africa.
    Orner P; Harries J; Cooper D; Moodley J; Hoffman M; Becker J; McGrory E; Dabash R; Bracken H
    Soc Sci Med; 2006 Aug; 63(4):968-78. PubMed ID: 16600447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbicides and HIV: help or hindrance?
    Karmon E; Potts M; Getz WM
    J Acquir Immune Defic Syndr; 2003 Sep; 34(1):71-5. PubMed ID: 14501797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaginal microbicides for reducing the risk of sexual acquisition of HIV infection in women: systematic review and meta-analysis.
    Obiero J; Mwethera PG; Hussey GD; Wiysonge CS
    BMC Infect Dis; 2012 Nov; 12():289. PubMed ID: 23130761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaginal microbicides save money: a model of cost-effectiveness in South Africa and the USA.
    Verguet S; Walsh JA
    Sex Transm Infect; 2010 Jun; 86(3):212-6. PubMed ID: 20522634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The implications of post-coital intravaginal cleansing for the introduction of vaginal microbicides in South Africa.
    Gafos M; Pool R; Mzimela MA; Ndlovu HB; McCormack S; Elford J;
    AIDS Behav; 2014 Feb; 18(2):297-310. PubMed ID: 24337726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Communication About Microbicide Use Between Couples in KwaZulu-Natal, South Africa.
    Gafos M; Pool R; Mzimela MA; Ndlovu HB; McCormack S; Elford J;
    AIDS Behav; 2015 May; 19(5):832-46. PubMed ID: 25488170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An assessment of the likely acceptability of vaginal microbicides for HIV prevention among women in rural Ghana.
    Abdulai MA; Baiden F; Adjei G; Afari-Asiedu S; Adjei K; Tawiah C; Newton S
    BMC Womens Health; 2012 Nov; 12():40. PubMed ID: 23114222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing HIV prevention for women: a review of evidence from microbicide studies and considerations for gender-sensitive microbicide introduction.
    Doggett EG; Lanham M; Wilcher R; Gafos M; Karim QA; Heise L
    J Int AIDS Soc; 2015; 18(1):20536. PubMed ID: 26700845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical development of microbicides for the prevention of HIV infection.
    D'Cruz OJ; Uckun FM
    Curr Pharm Des; 2004; 10(3):315-36. PubMed ID: 14754390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.